 |
|
Topical Imiquimod for Acyclovir-Unresponsive Herpes Simplex Virus 2 Infection
Jeffrey Gilbert, MD;
Molly M. Drehs, MD;
Jeffrey M. Weinberg, MD
From the Montefiore Medical Center, Bronx, NY (Dr Gilbert), and St Luke's–Roosevelt Hospital Center, New York, NY (Drs Drehs and Weinberg).
Arch Dermatol. 2001;137:1015-1017.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
REPORT OF A CASE
A 34-year-old Hispanic man who had been diagnosed as having human immunodeficiency virus 5 years earlier presented with a 5-month history of herpes simplex virus (HSV) 2 infection of the penis. His CD4 cell count was 200/µL, and his viral load was undetectable. He had been receiving highly active antiretroviral therapy for 11 months. Before he developed HSV-2 infection, he had no history of genital herpes infection. Treatment was begun with acyclovir (400 mg 3 times daily for 1 month), with no improvement. Subsequently, the patient was treated with valacyclovir hydrochloride (1 g twice daily for 4 weeks) and then with famciclovir (500 mg 3 times daily for 4 weeks). Despite these multiple treatment attempts, he experienced no improvement and remained culture positive for HSV-2 (Figure 1).
Figure appears in full text version.
|
|
|
|
Figure 1. Genital erosions before initiation of imiquimod therapy.
|
|
|
THERAPEUTIC CHALLENGE
Herpes . . . [Full Text of this Article]
SOLUTION
COMMENT
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Topical Imiquimod in the Treatment of Metastatic Melanoma to Skin
Wolf et al.
Arch Dermatol 2003;139:273-276.
FULL TEXT
Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection
Pyles et al.
J. Virol. 2002;76:11387-11396.
ABSTRACT
| FULL TEXT
Imiquimod and Genital Herpes
Slade et al.
Arch Dermatol 2002;138:534-535.
FULL TEXT
|
